Bodenes, Laetitia
N’Guyen, Quang-Thang
Le Mao, Raphaël
Ferrière, Nicolas
Pateau, Victoire
Lellouche, François
L’Her, Erwan
Funding for this research was provided by:
Oxynov Inc.
Article History
Received: 22 September 2021
Accepted: 17 January 2022
First Online: 15 February 2022
Competing interests
: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr. Bodenes declares she has no conflict of interest related to this research. Mr N Guyen declares he has no conflict of interest related to this research. Dr Le mao declares he has no conflict of interest related to this research. Dr Ferriere declares he has no conflict of interest related to this research. Pr. L’Her is a consultant for GE healthcare, Sedana Medical, Smiths and Archeon. He is a co-inventor of the FreeO2 patent, cofounder and shareholder of Oxynov Inc. that commercializes FreeO<sub>2</sub>. Pr Lelouche has received research funding from Fisher Paykel and Hamilton Medical and received honorarium for consultancy from Oxynov. Ms Pateau was financed by research grant from Oxynov Inc. as a research assistant.